Public Profile

Jazz Pharmaceuticals

Jazz Pharmaceuticals plc, headquartered in Great Britain, is a leading biopharmaceutical company dedicated to developing innovative treatments for patients with serious conditions. Founded in 2003, Jazz has made significant strides in the industry, particularly in the areas of sleep medicine and neurology. The company’s core products, including Xyrem and Sunosi, are renowned for their unique formulations that address complex health issues such as narcolepsy and excessive daytime sleepiness. With a strong market position, Jazz Pharmaceuticals has achieved notable milestones, including strategic acquisitions that have expanded its therapeutic portfolio and global reach. Operating primarily in North America and Europe, Jazz Pharmaceuticals continues to focus on delivering high-quality, patient-centric solutions that enhance the quality of life for individuals facing challenging health conditions.

DitchCarbon Score

How does Jazz Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Jazz Pharmaceuticals's score of 25 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Jazz Pharmaceuticals's reported carbon emissions

Jazz Pharmaceuticals, headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, as a player in the pharmaceutical industry, Jazz Pharmaceuticals is likely aware of the growing importance of sustainability and may be exploring strategies to address carbon emissions in line with industry standards. The absence of data highlights an opportunity for the company to enhance transparency and set measurable climate commitments in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Jazz Pharmaceuticals's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Jazz Pharmaceuticals is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Jazz Pharmaceuticals is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis Pharmaceuticals Corporation

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Genentech

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Exelixis, Inc.

US
Health and social work services (85)
Updated 3 days ago

Novartis

CH
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Seagen Inc.

US
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Amneal

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers